Increased levels of KDM5A, KDM5B and FBXL10 have also been observed in hepatocellular carcinoma, gastric cancer, lung cancer, pancreatic ductal adenocarcinoma, bladder cancer, colorectal cancer and prostate cancer26,27. The gene discussed is KDM5A; the disease is lung cancer.